---
schema_version: "secwatch.filing_event.v1"
accession: "0001645113-22-000037"
form_type: "8-K"
ticker: "NVCR"
cik: "0001645113"
company_name: "NovoCure Ltd"
filed_at: "2022-04-13T23:59:59+00:00"
generated_at: "2026-06-26T07:41:07.152983+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# NovoCure director Sherilyn McCoy not standing for reelection at June 2022 annual meeting

## Summary
- Director Sherilyn McCoy informed NovoCure she will not stand for reelection at the June 8, 2022 annual meeting.
- Decision is not due to any disagreement with the company; she cites a desire to focus on other professional commitments.
- McCoy will continue to serve on the board until the expiration of her term at the annual meeting.
- NovoCure thanked McCoy for her service and significant contributions.

## SEC filing metadata
- accession: 0001645113-22-000037
- form_type: 8-K
- ticker: NVCR
- cik: 0001645113
- company_name: NovoCure Ltd
- filed_at: 2022-04-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1645113/000164511322000037/0001645113-22-000037-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1645113/000164511322000037/nvcr-20220411.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001645113-22-000037
- JSON: https://secwatch.observer/filing/0001645113-22-000037.json
- Plain text: https://secwatch.observer/filing/0001645113-22-000037.txt

## Key facts
- Executive change
  Sherilyn McCoy departed as Director at NovoCure Ltd.
  - Action: not stand for reelection
  - Role: Director
  source text: On April 11, 2022, Sherilyn McCoy, a Director of NovoCure Limited (the "Company") since 2018, notified the Company of her intention not to stand for reelection to the Board of Directors of the Company (the "Board") at the Company's 2022 annual general meeting of shareholders (the "Annual Meeting"), which is currently scheduled for June 8, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1645113/000164511322000037/0001645113-22-000037-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.